Transforming growth factor-1 in children with diabetic nephropathy

被引:7
作者
Sawires, Happy [1 ]
Botrous, Osama [2 ]
Aboulmagd, Abdelmegeed [2 ]
Madani, Nadia [3 ]
Abdelhaleem, Osama [4 ]
机构
[1] Cairo Univ, Pediat Nephrol & Transplantat Ctr, Cairo, Egypt
[2] Beni Suef Univ, Pediat Dept, Bani Suwayf, Egypt
[3] Cairo Univ, Microbiol Dept, Giza, Egypt
[4] Beni Suef Gen Hosp, Pediat Dept, Minist Hlth, Bani Suwayf, Egypt
关键词
Transforming growth factor; Type; 1; diabetes; Children; Diabetic nephropathy; Microalbuminuria; FACTOR-BETA; GENE-EXPRESSION; TGF-BETA; GROWTH-FACTOR-BETA-1; FACTOR-BETA(1); ACTIVATION; MELLITUS; GLUCOSE; PROTEIN; ONSET;
D O I
10.1007/s00467-018-4062-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundTransforming growth factor-1 (TGF-1) is a multifunctional cytokine that has numerous biological processes. Earlier research indicates that protein and mRNA production of TGF-1 are enhanced in the renal tissues of patients with diabetic nephropathy (DN). Our aim was to evaluate the role of TGF-1 in early prediction of DN in children with type 1 diabetes mellitus (T1DM).MethodsFifty patients with T1DM were enrolled in an observational study. Patients were eligible to participate if at least 3 years had passed since T1DM diagnosis. Patients were classified into two groups (A and B) according to the presence or absence of microalbuminuria, respectively. Serum TGF-1 was measured by ELISA in the patients.ResultsOut of the 50 studied patients with T1DM, there were 23 (46%) patients with microalbuminuria. There was a significant difference between patients in group A and B as regards TGF-1 (p<0.001). HbA1c had very little influence in controlling for the relationship between TGF-1 and disease duration. Diagnostic cutoff value of TGF-1 was 358.5pg/ml with sensitivity and specificity of 100%.ConclusionTGF-1 was significantly higher in children with DN in comparison with children without. It could be used as an early indicator of DN in children with T1DM with high sensitivity and specificity.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 23 条
  • [1] Transforming growth factor-β1 and diabetic nephropathy
    Chang, Albert S.
    Hathaway, Catherine K.
    Smithies, Oliver
    Kakoki, Masao
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (08) : F689 - F696
  • [2] Diabetic nephropathy and transforming growth factor-β:: Transforming our view of glomerulosclerosis and fibrosis build-up
    Chen, S
    Jim, B
    Ziyadeh, FN
    [J]. SEMINARS IN NEPHROLOGY, 2003, 23 (06) : 532 - 543
  • [3] Transforming growth factor β1 at clinical onset of Type 1 diabetes mellitus.: A pilot study
    Flores, L
    Näf, S
    Hernáez, R
    Conget, I
    Gomis, R
    Esmatjes, E
    [J]. DIABETIC MEDICINE, 2004, 21 (08) : 818 - 822
  • [4] Fukuda N, 2009, J NEPHROL, V22, P708
  • [5] Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
    Goldberg, Ronald B.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) : 3171 - 3182
  • [6] Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice
    Hathaway, Catherine K.
    Gasim, Adil M. H.
    Grant, Ruriko
    Chang, Albert S.
    Kim, Hyung-Suk
    Madden, Victoria J.
    Bagnell, C. Robert, Jr.
    Jennette, J. Charles
    Smithies, Oliver
    Kakoki, Masao
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (18) : 5815 - 5820
  • [7] Activation of transforming growth factor-β1 in diabetic kidney disease
    Hellmich, B
    Schellner, M
    Schatz, H
    Pfeiffer, A
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (03): : 353 - 359
  • [8] Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes
    Herder, Christian
    Brunner, Eric J.
    Rathmann, Wolfgang
    Strassburger, Klaus
    Tabak, Adam G.
    Schloot, Nanette C.
    Witte, Daniel R.
    [J]. DIABETES CARE, 2009, 32 (03) : 421 - 423
  • [9] Urinary transforming growth factor-β1 and α1-microglobulin in children and adolescents with type 1 diabetes
    Korpinen, E
    Teppo, AM
    Hukkanen, L
    Åkerblom, HK
    Grönhagen-Riska, C
    Vaarala, O
    [J]. DIABETES CARE, 2000, 23 (05) : 664 - 668
  • [10] The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-β, increases podocyte motility and albumin permeability
    Lee, Eun Young
    Chung, Choon Hee
    Khoury, Charbel C.
    Yeo, Tet Kin
    Pyagay, Petr E.
    Wang, Amy
    Chen, Sheldon
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 297 (01) : F85 - F94